Metabolic labeling and targeting of dendritic cells (DCs) to enhance DC cancer vaccines

Metabolic labeling and targeting of dendritic cells (DCs) to enhance DC cancer vaccines
Development of an adjuvant-conjugated extracellular vesicle (EV) cancer vaccine strategy
Integrating stereotactic body radiation therapy (SBRT) and dendritic cell (DC)-homing material for the development of an in situ cancer vaccine platform